An established South Korean cosmetic fabric design and supply company is available for a 100% share acquisition.
Founded in 2016, the company specializes in the design and supply of high-performance fabrics used in cosmetic mask sheets and toner pads. Its proprietary fabric designs are adopted by leading Korean beauty brands and cosmetics manufacturers.
Business Highlights
- FY2025 revenue of approximately USD 3.28 million, representing approximately 160% growth compared with FY2024.
- FY2025 EBITDA of approximately USD 0.56 million.
- 1H2026 revenue of approximately USD 2.59 million, representing 111% yearonyear growth.
- 1H2026 operating profit margin of 22.6%, compared with 16.1% in FY2025.
- Portfolio covering 45 fabricbased product groups and 22 OEM/ODM finished product groups.
- Highperformance stretch fabric accounted for 79% of fabric sales during 1H2026.
- Established supply relationships with major Korean cosmetics brands and manufacturers.
- Assetlight operating model, with production outsourced to three specialist manufacturing partners in China.
- Net debt of approximately USD 0.21 million as of June 2026.
Competitive Advantages
The company develops specialized cosmetic fabrics and works with brand owners during product planning and development. Once adopted into a finished cosmetic product, material specifications may require additional testing before replacement, supporting repeat customer relationships.
The outsourced manufacturing model supports operating leverage without requiring substantial in-house manufacturing infrastructure.
Growth Opportunities
Potential expansion opportunities include turnkey OEM/ODM finished products, overseas private-label distribution and the development of the company's own skincare brand.
Management targets FY2028 revenue of approximately USD 24.1 million and operating profit of approximately USD 5.3 million. These figures represent management projections and are subject to execution risks.
Transaction Overview
The sole shareholder is offering 100% of the company's existing shares, including a transfer of management control.
The indicative equity valuation range is approximately USD 6.9–9.7 million, subject to due diligence and transaction negotiations.
Further information is available to qualified buyers subject to confidentiality arrangements.
